Track the 엘앤케이바이오 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엘앤케이바이오 has recorded 61 insider filings. The latest transaction was reported on 27 February 2026 (Other). Among the most active insiders: 강국진. All data is free.
56
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
엘앤케이바이오 operates in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions in the medical field.